Skip to content
Company Analysis

Bausch + Lomb Corporation BLCO

A comprehensive view of key metrics, scores, and financial health for Bausch + Lomb Corporation

Overview of Bausch + Lomb Corporation

BLCO NYQ
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Mid Cap
Bausch + Lomb Corporation (BLCO), is a Mid Cap company, in the Medical Instruments & Supplies industry, last closed at $15.08, about 39.7% undervalued vs fair value, +22.3% 1Y return, ranked 715/1122 in sector.
Metrics Rev Growth 6.5% ROE -5.6% Gross Margin 58.7%
USD 15.08
-1.37%
(Delayed)
• Vol 90d: 31.1%
52-Week Range
Market Cap
$5.44B
Enterprise Value
$10.43B
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Fair
Health
Good
Efficiency
Weak
Valuation
Fair
Growth
Weak
Profitability
Fair
Health
Good
Efficiency
Weak
Valuation
Fair
Completeness: 70%
Confidence: 83%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.bausch.com
HQ Vaughan, ON
Employees 13,000
Fiscal year Dec 31

Next Events

Earnings Jul 29 Estimated

Fair Value Snapshot

Bear Base Bull
$18
$21
$24
Current: $15.08 +40% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$5.1B
6.5%%
Gross Profit
$3.0B
2.6%%
Operating Income (GAAP)
$159.0M
-22.8%%
EBITDA
$572.0M
-4.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
58.7%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$12.0M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
7
Active Leaks
0/7
Improving
1
High Impact
4
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Bausch + Lomb Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
63
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
71
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing BLCO's balance between Growth (26.1%), Profitability (34.6%), and Safety (39.3%). Growth 26% Safety 39% Profitability 35%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

46th percentile vs peers
47
Key Signals
Rev Growth YoY 6.5% 52p Revenue CAGR 3Y 10.6% 56p EPS Growth YoY -21.5% 23p Asset Growth YoY 4.1% 64p
Strengths
  • Net Debt/EBITDA in top 20% of peers (7.45, 88th percentile)
  • D/E Ratio in top 20% of peers (83.3%, 82th percentile)
  • Consistently strong margins across 3 metrics
Risks

No significant risks identified for this axis.

Profitability

61th percentile vs peers
62
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

70th percentile vs peers
70
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Bausch + Lomb Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$21.06
- - -
+39.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000